Letter to the editor: Neutralizing antibodies for the treatment of COVID-19

Detalles Bibliográficos
Autores principales: Zhou, Zeqi, Wang, Xiangbin, Fu, Yankai, Zhang, Xiqing, Liu, Changxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668178/
https://www.ncbi.nlm.nih.gov/pubmed/33224722
http://dx.doi.org/10.1016/j.apsb.2020.10.025
_version_ 1783610442373922816
author Zhou, Zeqi
Wang, Xiangbin
Fu, Yankai
Zhang, Xiqing
Liu, Changxiao
author_facet Zhou, Zeqi
Wang, Xiangbin
Fu, Yankai
Zhang, Xiqing
Liu, Changxiao
author_sort Zhou, Zeqi
collection PubMed
description
format Online
Article
Text
id pubmed-7668178
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76681782020-11-16 Letter to the editor: Neutralizing antibodies for the treatment of COVID-19 Zhou, Zeqi Wang, Xiangbin Fu, Yankai Zhang, Xiqing Liu, Changxiao Acta Pharm Sin B Letter to the Editor Elsevier 2021-01 2020-11-16 /pmc/articles/PMC7668178/ /pubmed/33224722 http://dx.doi.org/10.1016/j.apsb.2020.10.025 Text en © 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Zhou, Zeqi
Wang, Xiangbin
Fu, Yankai
Zhang, Xiqing
Liu, Changxiao
Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
title Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
title_full Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
title_fullStr Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
title_full_unstemmed Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
title_short Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
title_sort letter to the editor: neutralizing antibodies for the treatment of covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668178/
https://www.ncbi.nlm.nih.gov/pubmed/33224722
http://dx.doi.org/10.1016/j.apsb.2020.10.025
work_keys_str_mv AT zhouzeqi lettertotheeditorneutralizingantibodiesforthetreatmentofcovid19
AT wangxiangbin lettertotheeditorneutralizingantibodiesforthetreatmentofcovid19
AT fuyankai lettertotheeditorneutralizingantibodiesforthetreatmentofcovid19
AT zhangxiqing lettertotheeditorneutralizingantibodiesforthetreatmentofcovid19
AT liuchangxiao lettertotheeditorneutralizingantibodiesforthetreatmentofcovid19

Ejemplares similares